Cargando…
Acute minocycline administration reduces brain injury and improves long-term functional outcomes after delayed hypoxemia following traumatic brain injury
Clinical trials of therapeutics for traumatic brain injury (TBI) demonstrating preclinical efficacy for TBI have failed to replicate these results in humans, in part due to the absence of clinically feasible therapeutic windows for administration. Minocycline, an inhibitor of microglial activation,...
Autores principales: | Celorrio, Marta, Shumilov, Kirill, Payne, Camryn, Vadivelu, Sangeetha, Friess, Stuart H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796448/ https://www.ncbi.nlm.nih.gov/pubmed/35090569 http://dx.doi.org/10.1186/s40478-022-01310-1 |
Ejemplares similares
-
Gut microbial regulation of innate and adaptive immunity after traumatic brain injury
por: Celorrio, Marta, et al.
Publicado: (2023) -
Gut-brain axis in traumatic brain injury: impact on neuroinflammation
por: Celorrio, Marta, et al.
Publicado: (2021) -
Delayed Hypoxemia Following Traumatic Brain Injury Exacerbates White Matter Injury
por: Parikh, Umang, et al.
Publicado: (2016) -
Gut microbial dysbiosis after traumatic brain injury modulates the immune response and impairs neurogenesis
por: Celorrio, Marta, et al.
Publicado: (2021) -
Better together? Treating traumatic brain injury with minocycline plus N-acetylcysteine
por: Lawless, Siobhán, et al.
Publicado: (2022)